Skip to content

Qualitative analysis of a patient’s experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs.

Dan Petrovitch, Jacob Spinks, Hannah B Yoo, Lindsay Kerr, Joshua Willms, Mary Katherine Jurek, Rachel Wanzor-Box, Andrew K. Littlefield, Ben McCauley

preprint DOI: 10.31234/osf.io/f53wp_v1

Summary

AI-generated from the abstract

A 28-year-old woman with alcohol and prescription opioid misuse underwent a collaborative treatment plan that combined ketamine-assisted psychotherapy with existing psychosocial and 12-step-based treatments. The patient attributed psychological and spiritual changes to her ketamine treatments, and her ketamine-induced experiences overlapped with the 12 steps. The report details clinical practices for managing the unique risks of ketamine interventions as substance use disorder treatments.

Study at a glance

Characteristics Case study Qualitative Case report
Sample size 1
Population 28-year-old female with substance use disorder involving alcohol and prescription opioids
Interventions Ketamine-assisted psychotherapy 12-step-based treatment
Key finding Ketamine-assisted psychotherapy combined with psychosocial and 12-step-based treatments may support recovery in a patient with substance use disorder, with ketamine-induced experiences overlapping with the 12 steps.

Abstract

Ketamine has demonstrated early promise for treating substance use disorder (SUD). However, ketamine is also a recreational substance, which raises concerns about its clinical applications to SUD. Despite the emerging evidence for ketamine-based approaches for SUD and these potential risks, little has been published on methods for integrating ketamine-assisted psychotherapy (KAP) with existing pharmacologic, psychosocial, and community-based treatment paradigms (e.g., 12-step programs). Here, we present the case of a 28-year-old female treated for SUD involving misuse of alcohol and prescription opioids. We executed an inter-clinic, collaborative treatment plan that involved a psychedelic, ketamine-based regimen in combination with extant psychosocial and 12-step-based treatments for SUD. Qualitative analysis of the patient’s lived experience suggested that ketamine played an important role in her self-reported experience of recovery, as she attributed psychological and spiritual changes to her ketamine treatments. Specifically, this report highlights the extent to which the patient’s ketamine-induced experiences overlapped with the 12 steps, which will be useful for clinicians treating other 12-step-involved SUD patients with ketamine. Additionally, we detail specific clinical practices that we implemented for managing the unique risks of ketamine interventions as SUD treatments.

Comments

No comments yet.

Log in to comment